This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Herpes Labialis Treatment Market

Market Insights on Herpes Labialis Treatment covering sales outlook, demand forecast & up-to-date key trends

Herpes Labialis Treatment Market By Drug Type (Acyclovir, Valacyclovir, Penciclovir, Famciclovir, Docosanol), Route of Administration (Oral, topical, Combination), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies) & Region - Forecast 2022 - 2028

Herpes Labialis Treatment Market Snapshot

[218 Pages Report] The global Herpes Labialis Treatment Market is expected to register a CAGR of nearly 4.7% over the forecast period (2022-2028) owing to increasing cases of recurrent herpes simplex infections. The herpes labialis treatment market recorded sales worth U.S. $ 1.03 Bn in the year 2021 and is expected to reach U.S. $ 1.42 Bn by the year 2028, according to the Future Market Insights (FMI) study.

The herpes labialis treatment market accounts for nearly 2% of the market share by value of the overall Antiviral Drugs Market, which was valued at nearly US$ 52.7 Bn in the year 2020. The herpes labialis treatment market experienced an increase in the demand in the past few year owing to the rising prevalence of herpes labialis infections around the world. Herpes labialis is caused by herpes simplex virus (HSV), which primarily affects the lips and are alternatively called as cold sores. According to the World Health Organization’s 2020 statistics, approximately 3.7 million people suffered from HSV 1 infection globally.

Various countries are focusing on prevention of viral diseases to reduce their healthcare costs, which in turn, is expected to result in high demand for advanced treatment options and diagnostic processes from local governments and third-party payers. Unavailability of effective diagnostic processes and treatment process has triggered the need for cost-effective treatment options with high specificity and sensitivity.

As a result, companies operating in herpes labialis treatment market are currently focusing on the development of cost-effective treatment processes. Moreover, increasing research and development activities to develop highly specific antifungal products are also expected to create new growth opportunities for manufacturers operating in antiviral treatment market.

Currently, several countries are still unaware about antiviral treatment (Cure). In several low income countries, physicians depend on antibacterial and steroids for the treatment process. Awareness about effective treatment procedures in these countries is very low. However, these countries have a large patient pool and hence, various companies are trying to enter into these markets by offering better quality and affordable antiviral products.

The topical mode of drug administration for the treatment of herpes labialis is preferred by the patients, since it provides immediate symptomatic relief for the cold sores affecting the lips. Thus, this novel mode of treatment will provide many lucrative opportunities for the manufacturers in the herpes labialis treatment market over the forecast period.

The sales of acyclovir in the year 2021 are expected to reach U.S. $ 305.4 Mn, which accounts for approximately 30% of the total herpes labialis treatment market. Acyclovir is the most commonly used anti-viral for the treatment of HSV1 infections, which present the manufacturers with numerous profitable opportunities in the near future.

Herpes Labialis Treatment Market Outlook:

Data Points

Market Insights

Market Value 2022

USD 1.07 Bn

Market Value 2028

USD 1.42 Bn

CAGR 2022-2028

4.7%

Share of Top 5 Countries

51.9%

Key Players

The key players of this industry are Novartis AG, Valeant Pharmaceuticals International Inc. (Bausch Health), Pfizer Inc., Abbott laboratories, Sun Pharmaceutical Industries, Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Plc., and Dr. Reddy’s Laboratories.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

4.59%

H1, 2022 Projected

4.74%

H1, 2022 Outlook

4.64%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 10 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(+) 05 ↑

As per analysis conducted by Future Market Insights, the market will increase by 05 Basis Point Share (BPS) in H1 2022 (O), as compared with H1-2021. The variation between the BPS values observed within this market in H1, 2022 - Outlook over H1, 2022 Projected reflects a decline of 10 BPS.

Major reasons for this rise in BPS is attributed to increasing developments in topical treatment of herpes labialis. Other market segments are also set to perform fairly and attain promising growth prospects in the next half of projection period.  

The herpes labialis treatment market is conditioned upon by regulatory approvals and innovation aspects in accordance with impact of macro and industry factors. FMI presents a comparative analysis about the growth rates and development prospects of the market on a global scale.

The development and approval of acyclovir for the treatment of life-threatening HSV illness and presence of alternatives to treat skin lesions caused by HSV are major progresses in this market. 

Apart from the above mentioned factors, there are some restrictive factors which affect the industry growth, including resistance of some HSV variants to therapy with nucleoside analogs with antiviral activity in immunosuppressed individuals, and lack of prophylactic approach for HSV-1 and HSV-2 in form of a vaccine. 

2012-2021 Herpes Labialis Treatment Demand Outlook Compared to 2022-2028 Forecast

According to the study by Future Market Insights (FMI), the herpes labialis treatment market expanded at the cumulative CAGR of 4.2% between 2012 and 2021. Increased investments in the R&D activities by the governmental authorities as well as the key players of this market, rising prevalence of HSV infections, the paradigm shift of governments towards preventive treatments for viral infections are some of the key drivers of the herpes labialis treatment market.

In November 2017, the U.S. FDA published latest guidelines for the development of antiviral drugs specifically for the management of recurrent herpes labialis (RHL). These guidelines were made to help investigate the safety testing which is of utmost importance for the approval of any antiviral drug.

The key players of herpes labialis treatment market are adopting strategies such as acquisition to increase their product portfolio and thereby improve their market presence worldwide.

In August 2016, Teva Pharmaceuticals announced the acquisition of Actavis Generics, which helped the company to get a stronger hold in the generics market and expand their product portfolio across the world.

In April 2021, Pfizer Inc., announced the acquisition of Amplyx Pharmaceuticals, a U.S. based company to help them advance their anti-infective pipeline, and expand their product portfolio of antifungals and antiviral treatments.

Herpes Labialis Treatment Market Download Report Brochure

The herpes labialis treatment market is consolidated by players such as Novartis AG, Valeant Pharmaceuticals International Inc. (Bausch Health), Pfizer Inc., Abbott laboratories, Sun Pharmaceutical Industries, Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Plc., and Dr. Reddy’s Laboratories.

Future Market Insights expects the herpes labialis treatment market to expand at a CAGR of 4.7% over the forecast period. Increased R&D activities in this field, key players participating in acquisitions are some of the factors which are contributing to the market expansion.

What is the Impact of the COVID-19 Crisis on the Market?

Many studies were conducted to study the association between herpes simplex virus and SARS-CoV-2 virus which suggested that reactivation of herpes simplex virus may occur in immunocompromised patients suffering from COVID-19. Not many researchers could prove the exact prevalence of this association.

In an article “Herpes simplex and herpes zoster viruses in COVID-19 patients”, published in the National Library of Medicine, stated that the prevalence of HSV infections in COVID-19 patients was less than 3%. Because of these research articles being published and associated fears, the COVID-19 pandemic affected the herpes labialis treatment market positively.

The COVID-19 pandemic, on the other hand, disrupted not only research and development of other therapies and drugs for medical conditions other than COVID-19, but also treatment procedures and pharmaceutical supply chains around the world.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Key Opportunities for Manufacturers of Herpes Labialis Treatment Industry?

Vaccines have protected millions of people from a variety of infectious diseases, but not herpes. Despite 50 years of trying, an effective preventative vaccine has eluded scientists. The scientists are trying to develop ingenious method to stop herpes virus to evade the immune system and infect the human body. Companies are increasing research and development for the treatment and prevention of herpes diseases.

Most of the companies are focusing on approval and launch of generic drugs in the undeveloped countries to provide low cost drugs for the treatment of viral infections. Thus, innovations to prevent the HSV infection, and emerging markets in the developing countries are expected to provide lucrative opportunities for the manufacturers of herpes labialis treatment market.

What are the Restraining Factors for this Market?

Most of the companies are facing difficulties in bringing herpes vaccines to the market without greater predictability and transparency from the U.S. FDA. Also, companies are facing difficulty in the clinical trial of vaccines/ drug candidates as well as delays in the timeline for approval in the U.S. market.

No permanent cure options are available for the treatment of herpes infection. The therapies only make the condition easier for patients, so mostly people don’t go for the treatment unless the cold sore reappears or reoccurs. This might hamper the growth of the herpes labialis treatment market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Insights

Will the U.S. Remain a key Market for Herpes Labialis Treatment?

In 2022, the U.S. is estimated to account for over 92.0% value share in North America. The rising number of herpes simplex virus infections is positively impacting the demand for number of research and development activities focusing on the development of drugs used in herpes labialis treatment, which is expected to drive the demand for this market in the U.S.

Why Germany is Considered a More Lucrative market Within Europe?

Germany is expected to hold nearly 22% share by value of the total herpes labialis treatment market in Western Europe in the year 2022. Increasing patient population suffering from HSV infections and improved healthcare infrastructure are contributing to the rapidly growing market in Germany.

What are the Factors Supporting Herpes Labialis Treatment Sales in China?

China is expected to account for 44.3% share by value in the year 2022, of the total herpes labialis treatment market in the Asia Pacific and the market is expected to expand at a cumulative CAGR of 6.1% over the forecast period. Rapidly developing healthcare infrastructure, increased healthcare spending, rising levels of patient awareness about sexually transmitted diseases are some of the factors positively affecting the demand for herpes labialis treatment market in China.

Herpes Labialis Treatment Market - Category-wise Insights

Why is the Demand for Acyclovir Drug Increasing?

Acyclovir is the most commonly used drug for the treatment of cold sores. Because of this, the sales for this drug are expected to be worth U.S. $ 321.3 Mn in the year 2022 and the demand for acyclovir is expected to expand at a CAGR of 5.1% over the forecast period.

Which is the most Preferred Route of Administration for the Treatment of Herpes Labialis?

The topical route of administration will hold 43.7% market share of the total herpes labialis treatment market by the end of 2021 since this novel mode of drug administration provides instant relief to the patients suffering from HSV infections.

Why Hospitals Contribute to Highest Market Share by Distribution Channels?

In terms of distribution channel, the hospitals will account for 35.4% of the market share in 2021 indicating high sales of herpes labialis treatment drugs from the hospital pharmacies. Since, the number of herpes labialis patients who opt for treatment at hospitals is increasing, they contribute to the highest share.

Herpes Labialis Treatment Market - Competitive Landscape

The key players of herpes labialis treatment market are actively seeking product approvals, undertaking strategic acquisitions to improve their presence in the market and strengthen their foothold in the industry.

In January 2018, Dr. Reddy’s Laboratories announced acquisition of 8 Abbreviated New Drug Applications (ANDA) from Teva Pharmaceuticals along with an affiliate of Allergan PLC in the U.S. This acquisition helped Dr. Reddy’s Laboratories to acquire Teva’s generic product portfolio which they gained after acquiring Allergan’s generic business.

In July 2021, GlaxoSmithKline announced the U.S. FDA approval of their herpes zoster recombinant vaccine, Shingrix, which can be used for the prevention of herpes zoster in adults above 18 years of age who are at risk of contracting this infection due to any known causes of immunosuppression.

Innovative product launches, unavailability of confirmed treatment for HSV infections, unavailability of proven vaccination for herpes simplex and herpes zoster infections are some of the key opportunities which could prove beneficial for the manufacturers of herpes labialis treatment market.

Herpes Labialis Treatment Market - Scope of the Report

Attribute

Details

Forecast Period

2022-2028

Historical Data Available for

2012-2021

Market Analysis

USD Million for Value.

Key Countries Covered

US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa

Key Segments Covered

Product type, Distribution Channel, and Region

Key Companies Profiled

  • Novartis AG
  • Valeant Pharmaceuticals International Inc. (Bausch Health)
  • Teva Pharmaceuticals Industries Ltd.
  • Sun Pharmaceuticals
  • Abbott laboratories
  • Mylan N.V.
  • Pfizer Inc.
  • GlaxoSmithKline PLC.
  • Dr. Reddy’s Laboratories

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Herpes Labialis Treatment by Category

Drug Type:

  • Acyclovir
  • Valacyclovir
  • Penciclovir
  • Famciclovir
  • Docosanol
  • Others

Route of Administration:

  • Oral
  • Topical
  • Combination

Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • MEA

Frequently Asked Questions

The sales of herpes labialis treatment are expected to be worth U.S. $ 1.03 Bn by the end of 2021, with a projected CAGR of 4.7% over the forecast period (2022-2028).

North America currently holds the largest market share in the herpes labialis treatment with over 34.0% of the global market share, and U.S. being the leading contributor in this region.

Acyclovir is leading the drug type segment with over 29% of the overall Herpes labialis treatment market share by value.

The Herpes labialis treatment in India is likely to grow at a CAGR of 5.5% during the forecast period, with a market value share of around 21.0% in 2021 of the APEJ market. The major factors that are adding growth to the Indian herpes labialis treatment are increased R&D activities, improving pharmaceutical industry sector and presence of key manufacturers of the industry.

Increasing research on preventive therapies for herpes simplex and herpes zoster infections, innovative product launches, growing prevalence of herpes labialis infections, unavailability of ascertained treatment for the infection, emerging markets in the developing economies are some of the key drivers of Herpes labialis treatment market.

Japan’s market is expected to witness steady growth and expand at a 3.5% CAGR during the forecast period. The market in Japan is expected to record sales of U.S. $ 44.7 Mn in the year 2021.

United States, China, Germany, Japan and South Africa are the top 5 countries that are driving the demand for Herpes labialis treatment.

Leading companies of Herpes labialis treatment are Novartis AG, Valeant Pharmaceuticals International Inc. (Bausch Health), Pfizer Inc., Abbott laboratories, Sun Pharmaceutical Industries, Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Plc., and Dr. Reddy’s Laboratories.

Table of Content

1. Executive Summary

    1.1. Overview

    1.2. Market Analysis

    1.3. FMI Analysis and Recommendations

    1.4. Wheel of Fortune

2. Market Introduction

    2.1. Market Taxonomy

    2.2. Market Definition

3. Herpes Labialis Treatment Market View Point 

    3.1. Macro-Economic Factors

    3.2. Opportunity Analysis

4. North America Herpes Labialis Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    4.1. Introduction

    4.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        4.2.1. U.S.

        4.2.2. Canada

    4.3. Market Size (US$ Mn) Forecast By Country, 2022-2028

        4.3.1. U.S.

        4.3.2. Canada

    4.4. Historical Market Size (US$ Mn) and Analysis By Drug Class, 2012-2021

        4.4.1. Acyclovir

        4.4.2. Valacyclovir

        4.4.3. Penciclovir

        4.4.4. Famciclovir

        4.4.5. Docosanol

        4.4.6. Others

    4.5. Market Size (US$ Mn) and Forecast By Drug Class, 2022-2028

        4.5.1. Acyclovir

        4.5.2. Valacyclovir

        4.5.3. Penciclovir

        4.5.4. Famciclovir

        4.5.5. Docosanol

        4.5.6. Others

    4.6. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        4.6.1. Oral

        4.6.2. Topical

        4.6.3. Combination

    4.7. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

        4.7.1. Oral

        4.7.2. Topical

        4.7.3. Combination

    4.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        4.8.1. Hospital Pharmacies

        4.8.2. Retail Pharmacies

        4.8.3. Drug Stores

        4.8.4. Online Pharmacies

    4.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

        4.9.1. Hospital Pharmacies

        4.9.2. Retail Pharmacies

        4.9.3. Drug Stores

        4.9.4. Online Pharmacies

    4.10. Market Attractiveness Analysis

        4.10.1. By Country

        4.10.2. By Drug Class

        4.10.3. By Route of Administration

        4.10.4. By Distribution Channel

    4.11. Key Participants Market Presence (Intensity Map)

5. Latin America Herpes Labialis Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    5.1. Introduction

    5.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        5.2.1. Brazil

        5.2.2. Mexico

        5.2.3. Rest of Latin America

    5.3. Market Size (US$ Mn) Forecast By Country, 2022-2028

        5.3.1. Brazil

        5.3.2. Mexico

        5.3.3. Rest of Latin America

    5.4. Historical Market Size (US$ Mn) and Analysis By Drug Class, 2012-2021

        5.4.1. Acyclovir

        5.4.2. Valacyclovir

        5.4.3. Penciclovir

        5.4.4. Famciclovir

        5.4.5. Docosanol

        5.4.6. Others

    5.5. Market Size (US$ Mn) and Forecast By Drug Class, 2022-2028

        5.5.1. Acyclovir

        5.5.2. Valacyclovir

        5.5.3. Penciclovir

        5.5.4. Famciclovir

        5.5.5. Docosanol

        5.5.6. Others

    5.6. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        5.6.1. Oral

        5.6.2. Topical

        5.6.3. Combination

    5.7. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

        5.7.1. Oral

        5.7.2. Topical

        5.7.3. Combination

    5.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        5.8.1. Hospital Pharmacies

        5.8.2. Retail Pharmacies

        5.8.3. Drug Stores

        5.8.4. Online Pharmacies

    5.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

        5.9.1. Hospital Pharmacies

        5.9.2. Retail Pharmacies

        5.9.3. Drug Stores

        5.9.4. Online Pharmacies

    5.10. Market Attractiveness Analysis

        5.10.1. By Country

        5.10.2. By Drug Class

        5.10.3. By Route of Administration

        5.10.4. By Distribution Channel

    5.11. Key Participants Market Presence (Intensity Map)

6. Western Europe Herpes Labialis Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    6.1. Introduction

    6.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        6.2.1. Germany

        6.2.2. Italy

        6.2.3. France

        6.2.4. Spain

        6.2.5. U.K.

        6.2.6. BENELUX

        6.2.7. Nordic

        6.2.8. Rest of Western Europe

    6.3. Market Size (US$ Mn) Forecast By Country, 2022-2028

        6.3.1. Germany

        6.3.2. Italy

        6.3.3. France

        6.3.4. Spain

        6.3.5. U.K.

        6.3.6. BENELUX

        6.3.7. Nordic

        6.3.8. Rest of Western Europe

    6.4. Historical Market Size (US$ Mn) and Analysis By Drug Class, 2012-2021

        6.4.1. Acyclovir

        6.4.2. Valacyclovir

        6.4.3. Penciclovir

        6.4.4. Famciclovir

        6.4.5. Docosanol

        6.4.6. Others

    6.5. Market Size (US$ Mn) and Forecast By Drug Class, 2022-2028

        6.5.1. Acyclovir

        6.5.2. Valacyclovir

        6.5.3. Penciclovir

        6.5.4. Famciclovir

        6.5.5. Docosanol

        6.5.6. Others

    6.6. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        6.6.1. Oral

        6.6.2. Topical

        6.6.3. Combination

    6.7. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

        6.7.1. Oral

        6.7.2. Topical

        6.7.3. Combination

    6.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        6.8.1. Hospital Pharmacies

        6.8.2. Retail Pharmacies

        6.8.3. Drug Stores

        6.8.4. Online Pharmacies

    6.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

        6.9.1. Hospital Pharmacies

        6.9.2. Retail Pharmacies

        6.9.3. Drug Stores

        6.9.4. Online Pharmacies

    6.10. Market Attractiveness Analysis

        6.10.1. By Country

        6.10.2. By Drug Class

        6.10.3. By Route of Administration

        6.10.4. By Distribution Channel

    6.11. Key Participants Market Presence (Intensity Map)

7. Asia Pacific excluding Japan Herpes Labialis Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    7.1. Introduction

    7.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        7.2.1. China

        7.2.2. India

        7.2.3. Australia and New Zealand

        7.2.4. ASEAN

        7.2.5. Rest of APEJ

    7.3. Market Size (US$ Mn) Forecast By Country, 2022-2028

        7.3.1. China

        7.3.2. India

        7.3.3. Australia and New Zealand

        7.3.4. ASEAN

        7.3.5. Rest of APEJ

    7.4. Historical Market Size (US$ Mn) and Analysis By Drug Class, 2012-2021

        7.4.1. Acyclovir

        7.4.2. Valacyclovir

        7.4.3. Penciclovir

        7.4.4. Famciclovir

        7.4.5. Docosanol

        7.4.6. Others

    7.5. Market Size (US$ Mn) and Forecast By Drug Class, 2022-2028

        7.5.1. Acyclovir

        7.5.2. Valacyclovir

        7.5.3. Penciclovir

        7.5.4. Famciclovir

        7.5.5. Docosanol

        7.5.6. Others

    7.6. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        7.6.1. Oral

        7.6.2. Topical

        7.6.3. Combination

    7.7. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

        7.7.1. Oral

        7.7.2. Topical

        7.7.3. Combination

    7.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        7.8.1. Hospital Pharmacies

        7.8.2. Retail Pharmacies

        7.8.3. Drug Stores

        7.8.4. Online Pharmacies

    7.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

        7.9.1. Hospital Pharmacies

        7.9.2. Retail Pharmacies

        7.9.3. Drug Stores

        7.9.4. Online Pharmacies

    7.10. Market Attractiveness Analysis

        7.10.1. By Country

        7.10.2. By Drug Class

        7.10.3. By Route of Administration

        7.10.4. By Distribution Channel

    7.11. Key Participants Market Presence (Intensity Map)

8. Japan Herpes Labialis Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    8.1. Introduction

    8.2. Historical Market Size (US$ Mn) and Analysis By Drug Class, 2012-2021

        8.2.1. Acyclovir

        8.2.2. Valacyclovir

        8.2.3. Penciclovir

        8.2.4. Famciclovir

        8.2.5. Docosanol

        8.2.6. Others

    8.3. Market Size (US$ Mn) and Forecast By Drug Class, 2022-2028

        8.3.1. Acyclovir

        8.3.2. Valacyclovir

        8.3.3. Penciclovir

        8.3.4. Famciclovir

        8.3.5. Docosanol

        8.3.6. Others

    8.4. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        8.4.1. Oral

        8.4.2. Topical

        8.4.3. Combination

    8.5. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

        8.5.1. Oral

        8.5.2. Topical

        8.5.3. Combination

    8.6. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        8.6.1. Hospital Pharmacies

        8.6.2. Retail Pharmacies

        8.6.3. Drug Stores

        8.6.4. Online Pharmacies

    8.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

        8.7.1. Hospital Pharmacies

        8.7.2. Retail Pharmacies

        8.7.3. Drug Stores

        8.7.4. Online Pharmacies

    8.8. Market Attractiveness Analysis

        8.8.1. By Country

        8.8.2. By Drug Class

        8.8.3. By Route of Administration

        8.8.4. By Distribution Channel

    8.9. Key Participants Market Presence (Intensity Map)

9. Middle East & Africa Herpes Labialis Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        9.2.1. GCC Countries

        9.2.2. South Africa

        9.2.3. Rest of MEA

    9.3. Market Size (US$ Mn) Forecast By Country, 2022-2028

        9.3.1. GCC Countries

        9.3.2. South Africa

        9.3.3. Rest of MEA

    9.4. Historical Market Size (US$ Mn) and Analysis By Drug Class, 2012-2021

        9.4.1. Acyclovir

        9.4.2. Valacyclovir

        9.4.3. Penciclovir

        9.4.4. Famciclovir

        9.4.5. Docosanol

        9.4.6. Others

    9.5. Market Size (US$ Mn) and Forecast By Drug Class, 2022-2028

        9.5.1. Acyclovir

        9.5.2. Valacyclovir

        9.5.3. Penciclovir

        9.5.4. Famciclovir

        9.5.5. Docosanol

        9.5.6. Others

    9.6. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        9.6.1. Oral

        9.6.2. Topical

        9.6.3. Combination

    9.7. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

        9.7.1. Oral

        9.7.2. Topical

        9.7.3. Combination

    9.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        9.8.1. Hospital Pharmacies

        9.8.2. Retail Pharmacies

        9.8.3. Drug Stores

        9.8.4. Online Pharmacies

    9.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

        9.9.1. Hospital Pharmacies

        9.9.2. Retail Pharmacies

        9.9.3. Drug Stores

        9.9.4. Online Pharmacies

    9.10. Market Attractiveness Analysis

        9.10.1. By Country

        9.10.2. By Drug Class

        9.10.3. By Route of Administration

        9.10.4. By Distribution Channel

    9.11. Key Participants Market Presence (Intensity Map)

10. Forecast Factors: Relevance and Impact

11. Forecast Assumptions

12. Competition Landscape

    12.1. Competition Dashboard

    12.2. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)

        12.2.1. Teva Pharmaceuticals, Inc.

        12.2.2. Abbott Laboratories

        12.2.3. Sun Pharmaceuticals Industries Ltd.

        12.2.4. Mylan N.V.

        12.2.5. Pfizer Inc.

        12.2.6. GlaxoSmithKline plc.

        12.2.7. Dr. Reddy’s Laboratories, ltd.

        12.2.8. Novartis AG

        12.2.9. Valeant Pharmaceuticals International Inc.

13. Global Herpes Labialis Treatment Market Analysis 2012-2021 and Forecast 2022-2028, By Region

    13.1. Introduction/Key Findings

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012-2021

        13.2.1. North America

        13.2.2. Latin America

        13.2.3. Western Europe

        13.2.4. Eastern Europe

        13.2.5. Asia Pacific excluding Japan

        13.2.6. Japan

        13.2.7. Middle East & Africa

    13.3. Market Size (US$ Mn) Forecast By Region, 2022-2028

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Western Europe

        13.3.4. Eastern Europe

        13.3.5. Asia Pacific excluding Japan

        13.3.6. Japan

        13.3.7. Middle East & Africa

    13.4. Market Attractiveness Analysis By Region

14. Global Herpes Labialis Treatment Market Analysis 2012-2021 and Forecast 2022-2028, By Drug Class

    14.1. Introduction/Key Findings

    14.2. Historical Market Size (US$ Mn) and Analysis By Drug Class, 2012-2021

        14.2.1. Acyclovir

        14.2.2. Valacyclovir

        14.2.3. Penciclovir

        14.2.4. Famciclovir

        14.2.5. Docosanol

        14.2.6. Others

    14.3. Market Size (US$ Mn) and Forecast By Drug Class, 2022-2028

        14.3.1. Acyclovir

        14.3.2. Valacyclovir

        14.3.3. Penciclovir

        14.3.4. Famciclovir

        14.3.5. Docosanol

        14.3.6. Others

    14.4. Market Attractiveness Analysis By Drug Class

15. Global Herpes Labialis Treatment Market Analysis 2012-2021 and Forecast 2022-2028, By Route of Administration 

    15.1. Introduction/Key Findings

    15.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        15.2.1. Oral

        15.2.2. Topical

        15.2.3. Combination

    15.3. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

        15.3.1. Oral

        15.3.2. Topical

        15.3.3. Combination

    15.4. Market Attractiveness Analysis By Route of Administration

16. Global Herpes Labialis Treatment Market Analysis 2012-2021 and Forecast 2022-2028, By Distribution Channel 

    16.1. Introduction/Key Findings

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2012-2021

        16.2.1. Hospital Pharmacies

        16.2.2. Retail Pharmacies

        16.2.3. Drug Stores

        16.2.4. Online Pharmacies

    16.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

        16.3.1. Hospital Pharmacies

        16.3.2. Retail Pharmacies

        16.3.3. Drug Stores

        16.3.4. Online Pharmacies

    16.4. Market Attractiveness Analysis By Distribution Channel

17. Global Herpes Labialis Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    17.1. Market Size and Y-o-Y Growth

    17.2. Absolute $ Opportunity

    17.3. Market Value Chain

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: North America Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Country

Table 02: North America Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Drug Type

Table 03: North America Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Route of Administration

Table 04: North America Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Distribution Channel

Table 05: Latin America Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Country

Table 06: Latin America Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Drug Type

Table 07: Latin America Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Route of Administration

Table 08: Latin America Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Distribution Channel

Table 09: Western Europe Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Country

Table 10: Western Europe Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Drug Type

Table 11: Western Europe Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Route of Administration

Table 12: Western Europe Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Distribution Channel

Table 13: Eastern Europe Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Country

Table 14: Eastern Europe Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Drug Type

Table 15: Eastern Europe Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Route of Administration

Table 16: Eastern Europe Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Distribution Channel

Table 17: APEJ Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Country

Table 18: APEJ Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Drug Type

Table 19: APEJ Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Route of Administration

Table 20: APEJ Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Distribution Channel

Table 21: Japan Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Drug Type

Table 22: Japan Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Route of Administration

Table 23: Japan Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Distribution Channel

Table 24: MEA Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Country

Table 25: MEA Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Drug Type

Table 26: MEA Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Route of Administration

Table 27: MEA Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Distribution Channel

Table 28: Global Herpes Labialis Treatment Market Size (US$ Mn) Forecast By Region, 2012–2021

Table 29: Global Herpes Labialis Treatment Market size Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Drug Type

Table 30: Global Herpes Labialis Treatment Market size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Route of Administration

Table 31: Global Herpes Labialis Treatment Market size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Total Pharmaceutical Spending, % of Health Spending, 2020

Figure 02: Per Capita Healthcare Spending

Figure 03: Estimates of new HSV-1 infections among people aged 0-49 in 2022

Figure 04: North America Herpes Labialis Treatment Market Split By Drug Type (2021)

Figure 05: North America Herpes Labialis Treatment Market Split By Route of Administration (2021)

Figure 06: North America Herpes Labialis Treatment Market Split By Distribution Channel (2021)

Figure 07: North America Herpes Labialis Treatment Market Split By Country (2021)

Figure 08: North America Herpes Labialis Treatment Market Size Analysis, 2012-2021

Figure 09: North America Herpes Labialis Treatment Market Forecast & Y-o-Y growth, 2022-2028

Figure 10: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Acyclovir Drug Type

Figure 11: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Acyclovir Drug Type

Figure 12: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Valacyclovir Drug Type

Figure 13: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022–2028, By Valacyclovir Drug Type

Figure 14: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Penciclovir Drug Type

Figure 15: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022–2028, By Penciclovir Drug Type

Figure 16: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Famciclovir Drug Type

Figure 17: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Famciclovir Drug Type

Figure 18: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Docosanol Drug Type

Figure 19: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022–2028, By Docosanol Drug Type

Figure 20: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Others Drug Type

Figure 21: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022–2028, By Others Drug Type

Figure 22: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Oral Route of Administration

Figure 23: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, Oral Route of Administration

Figure 24: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Topical Route of Administration

Figure 25: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, By Topical Route of Administration

Figure 26: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Combination Segment

Figure 27: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, By Combination Segment

Figure 28: North America Herpes Labialis Treatment Market Attractiveness Analysis By Drug Type, 2022-2028

Figure 29: North America Herpes Labialis Treatment Market Attractiveness Analysis By Route of Administration, 2022-2028

Figure 30: North America Herpes Labialis Treatment Market Attractiveness Analysis By Distribution Channel, 2022-2028

Figure 31: North America Herpes Labialis Treatment Market Attractiveness Analysis By Country, 2022-2028

Figure 32: Latin America Herpes Labialis Treatment Market Split By Drug Type (2021)

Figure 33: Latin America Herpes Labialis Treatment Market Split By Route of Administration (2021)

Figure 34: Latin America Herpes Labialis Treatment Market Split By Distribution Channel (2021)

Figure 35: Latin America Herpes Labialis Treatment Market Split By Country (2021)

Figure 36: Latin America Herpes Labialis Treatment Market Size Analysis, 2012-2021

Figure 37: Latin America Herpes Labialis Treatment Market Forecast & Y-o-Y growth, 2022-2028

Figure 38: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Acyclovir Drug Type

Figure 39: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Acyclovir Drug Type

Figure 40: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Valacyclovir Drug Type

Figure 41: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Valacyclovir Drug Type

Figure 42: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Penciclovir Drug Type

Figure 43: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Penciclovir Drug Type

Figure 44: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Famciclovir Drug Type

Figure 45: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Famciclovir Drug Type

Figure 46: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Docosanol Drug Type

Figure 47: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Docosanol Drug Type

Figure 48: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Others Drug Type

Figure 49: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Others Drug Type

Figure 50: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Oral Route of Administration

Figure 51: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, Oral Route of Administration

Figure 52: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Topical Route of Administration

Figure 53: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, By Topical Route of Administration

Figure 54: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Combination Segment

Figure 55: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, By Combination Segment

Figure 56: Latin America Herpes Labialis Treatment Market Attractiveness Analysis By Drug Type, 2022-2028

Figure 57: Latin America Herpes Labialis Treatment Market Attractiveness Analysis By Route of Administration, 2022-2028

Figure 58: Latin America Herpes Labialis Treatment Market Attractiveness Analysis By Distribution Channel, 2022-2028

Figure 59: Latin America Herpes Labialis Treatment Market Attractiveness Analysis By Country, 2022-2028

Figure 60: Western Europe Herpes Labialis Treatment Market Split By Drug Type (2021)

Figure 61: Western Europe Herpes Labialis Treatment Market Split By Route of Administration (2021)

Figure 62: Western Europe Herpes Labialis Treatment Market Split By Distribution Channel (2021)

Figure 63: Western Europe Herpes Labialis Treatment Market Split By Country (2021)

Figure 64: Western Europe Herpes Labialis Treatment Market Size Analysis, 2012-2021

Figure 65: Western Europe Herpes Labialis Treatment Market Forecast & Y-o-Y growth, 2022-2028

Figure 66: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Acyclovir Drug Type

Figure 67: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Acyclovir Drug Type

Figure 68: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Valacyclovir Drug Type

Figure 69: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Valacyclovir Drug Type

Figure 70: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Penciclovir Drug Type

Figure 71: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Penciclovir Drug Type

Figure 72: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Famciclovir Drug Type

Figure 73: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Famciclovir Drug Type

Figure 74: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Docosanol Drug Type

Figure 75: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Docosanol Drug Type

Figure 76: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Others Drug Type

Figure 77: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Others Drug Type

Figure 78: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Oral Route of Administration

Figure 79: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, Oral Route of Administration

Figure 80: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Topical Route of Administration

Figure 81: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, By Topical Route of Administration

Figure 82: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Combination Segment

Figure 83: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, By Combination Segment

Figure 84: Western Europe Herpes Labialis Treatment Market Attractiveness Analysis By Drug Type, 2022-2028

Figure 85: Western Europe Herpes Labialis Treatment Market Attractiveness Analysis By Route of Administration, 2022-2028

Figure 86: Western Europe Herpes Labialis Treatment Market Attractiveness Analysis By Distribution Channel, 2022-2028

Figure 87: Western Europe Herpes Labialis Treatment Market Attractiveness Analysis By Country, 2022-2028

Figure 88: Eastern Europe Herpes Labialis Treatment Market Split By Drug Type (2021)

Figure 89: Eastern Europe Herpes Labialis Treatment Market Split By Route of Administration (2021)

Figure 90 : Eastern Europe Herpes Labialis Treatment Market Split By Distribution Channel (2021)

Figure 91: Eastern Europe Herpes Labialis Treatment Market Split By Country (2021)

Figure 92: Eastern Europe Herpes Labialis Treatment Market Size Analysis, 2012-2021

Figure 93: Eastern Europe Herpes Labialis Treatment Market Forecast & Y-o-Y growth, 2022-2028

Figure 94: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Acyclovir Drug Type

Figure 95: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Acyclovir Drug Type

Figure 96: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Valacyclovir Drug Type

Figure 97: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Valacyclovir Drug Type

Figure 98: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Penciclovir Drug Type

Figure 99: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Penciclovir Drug Type

Figure 100: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Famciclovir Drug Type

Figure 101: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Famciclovir Drug Type

Figure 102: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Docosanol Drug Type

Figure 103: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Docosanol Drug Type

Figure 104: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Others Drug Type

Figure 105: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Others Drug Type

Figure 106: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Oral Route of Administration

Figure 107: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, Oral Route of Administration

Figure 108: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Topical Route of Administration

Figure 109: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, By Topical Route of Administration

Figure 110: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Combination Segment

Figure 111: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, By Combination Segment

Figure 112: Eastern Europe Herpes Labialis Treatment Market Attractiveness Analysis By Drug Type, 2022-2028

Figure 113: Eastern Europe Herpes Labialis Treatment Market Attractiveness Analysis By Route of Administration, 2022-2028

Figure 114: Eastern Europe Herpes Labialis Treatment Market Attractiveness Analysis By Distribution Channel, 2022-2028

Figure 115: Eastern Europe Herpes Labialis Treatment Market Attractiveness Analysis By Country, 2022-2028

Figure 116: APEJ Herpes Labialis Treatment Market Split By Drug Type (2021)

Figure 117: APEJ Herpes Labialis Treatment Market Split By Route of Administration (2021)

Figure 118: APEJ Herpes Labialis Treatment Market Split By Distribution Channel (2021)

Figure 119: APEJ Herpes Labialis Treatment Market Split By Country (2021)

Figure 120: APEJ Herpes Labialis Treatment Market Size Analysis, 2012-2021

Figure 121: APEJ Herpes Labialis Treatment Market Forecast & Y-o-Y growth, 2022-2028

Figure 122: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Acyclovir Drug Type

Figure 123: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Acyclovir Drug Type

Figure 124: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Valacyclovir Drug Type

Figure 125: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Valacyclovir Drug Type

Figure 126: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Penciclovir Drug Type

Figure 127: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Penciclovir Drug Type

Figure 128: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Famciclovir Drug Type

Figure 129: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Famciclovir Drug Type

Figure 130: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Docosanol Drug Type

Figure 131: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Docosanol Drug Type

Figure 132: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Others Drug Type

Figure 133: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Others Drug Type

Figure 134: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Oral Route of Administration

Figure 135: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, Oral Route of Administration

Figure 136: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Topical Route of Administration

Figure 137: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, By Topical Route of Administration

Figure 138: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Combination Segment

Figure 139: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, By Combination Segment

Figure 140: APEJ Herpes Labialis Treatment Market Attractiveness Analysis By Drug Type, 2022-2028

Figure 141: APEJ Herpes Labialis Treatment Market Attractiveness Analysis By Route of Administration, 2022-2028

Figure 142: APEJ Herpes Labialis Treatment Market Attractiveness Analysis By Distribution Channel, 2022-2028

Figure 143: APEJ Herpes Labialis Treatment Market Attractiveness Analysis By Country, 2022-2028

Figure 144: Japan Herpes Labialis Treatment Market Split By Drug Type (2021)

Figure 145: Japan Herpes Labialis Treatment Market Split By Route of Administration (2021)

Figure 146: Japan Herpes Labialis Treatment Market Split By Distribution Channel (2021)

Figure 147: Japan Herpes Labialis Treatment Market Size Analysis, 2012-2021

Figure 148: Japan Herpes Labialis Treatment Market Forecast & Y-o-Y growth, 2022-2028

Figure 149: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Acyclovir Drug Type

Figure 150: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Acyclovir Drug Type

Figure 151: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Valacyclovir Drug Type

Figure 152: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Valacyclovir Drug Type

Figure 153: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Penciclovir Drug Type

Figure 154: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Penciclovir Drug Type

Figure 155: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Famciclovir Drug Type

Figure 156: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Famciclovir Drug Type

Figure 157: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Docosanol Drug Type

Figure 158: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Docosanol Drug Type

Figure 159: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Others Drug Type

Figure 160: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Others Drug Type

Figure 161: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Oral Route of Administration

Figure 162: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, Oral Route of Administration

Figure 163: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Topical Route of Administration

Figure 164: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, By Topical Route of Administration

Figure 165: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Combination Segment

Figure 166: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, By Combination Segment

Figure 167: Japan Herpes Labialis Treatment Market Attractiveness Analysis By Drug Type, 2022-2028

Figure 168: Japan Herpes Labialis Treatment Market Attractiveness Analysis By Distribution Channel, 2022-2028

Figure 169: Japan Herpes Labialis Treatment Market Attractiveness Analysis By Route of Administration, 2022-2028

Figure 170: MEA Herpes Labialis Treatment Market Split By Drug Type (2021)

Figure 171: MEA Herpes Labialis Treatment Market Split By Route of Administration (2021)

Figure 172: MEA Herpes Labialis Treatment Market Split By Distribution Channel (2021)

Figure 173: MEA Herpes Labialis Treatment Market Split By Country (2021)

Figure 174: MEA Herpes Labialis Treatment Market Size Analysis, 2012-2021

Figure 175: MEA Herpes Labialis Treatment Market Forecast & Y-o-Y growth, 2022-2028

Figure 176: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Acyclovir Drug Type

Figure 177: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Acyclovir Drug Type

Figure 178: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Valacyclovir Drug Type

Figure 179: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Valacyclovir Drug Type

Figure 180: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Penciclovir Drug Type

Figure 181: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Penciclovir Drug Type

Figure 182: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Famciclovir Drug Type

Figure 183: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Famciclovir Drug Type

Figure 184: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Docosanol Drug Type

Figure 185: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Docosanol Drug Type

Figure 186: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Others Drug Type

Figure 187: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2022-2028, By Others Drug Type

Figure 189: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, Oral Route of Administration

Figure 188: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Oral Route of Administration

Figure 190: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Topical Route of Administration

Figure 191: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, By Topical Route of Administration

Figure 192: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012-2021, By Combination Segment

Figure 193: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028, By Combination Segment

Figure 194: MEA Herpes Labialis Treatment Market Attractiveness Analysis By Drug Type, 2022-2028

Figure 195: MEA Herpes Labialis Treatment Market Attractiveness Analysis By Route of Administration, 2022-2028

Figure 196: MEA Herpes Labialis Treatment Market Attractiveness Analysis By Distribution Channel, 2022-2028

Figure 197: MEA Herpes Labialis Treatment Market Attractiveness Analysis By Country, 2022-2028

Figure 198: Global Herpes Labialis Treatment Market Attractiveness Analysis By Region, 2022-2028

Figure 199: Global Herpes Labialis Treatment Market Attractiveness Analysis By Drug Type, 2022-2028

Figure 200: Global Herpes Labialis Treatment Market Attractiveness Analysis By Route of Administration, 2022-2028

Figure 201: Global Herpes Labialis Treatment Market Attractiveness Analysis By Distribution Channel, 2022-2028

Figure 202: Global Herpes Labialis Treatment Historical Market Size and Y-o-Y, 2012-2021

Figure 203: Global Herpes Labialis Treatment Projected Market Size (US$ Mn) and Y-o-Y, 2022 – 2028

Figure 204: Global Herpes Labialis Treatment Market Absolute $ Opportunity, 2012–2028

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Herpes Simplex Keratitis Treatment Market

Published : February 2019

Healthcare

Herpes Zoster Ophthalmicus Market

Published : February 2019

Healthcare

Genital Herpes Treatment Market

Published : July 2021

Google translate

Herpes Labialis Treatment Market